Cargando…
Gammaretroviral Vectors: Biology, Technology and Application
Retroviruses are evolutionary optimized gene carriers that have naturally adapted to their hosts to efficiently deliver their nucleic acids into the target cell chromatin, thereby overcoming natural cellular barriers. Here we will review—starting with a deeper look into retroviral biology—how Murine...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185771/ https://www.ncbi.nlm.nih.gov/pubmed/21994751 http://dx.doi.org/10.3390/v3060677 |
_version_ | 1782213263404040192 |
---|---|
author | Maetzig, Tobias Galla, Melanie Baum, Christopher Schambach, Axel |
author_facet | Maetzig, Tobias Galla, Melanie Baum, Christopher Schambach, Axel |
author_sort | Maetzig, Tobias |
collection | PubMed |
description | Retroviruses are evolutionary optimized gene carriers that have naturally adapted to their hosts to efficiently deliver their nucleic acids into the target cell chromatin, thereby overcoming natural cellular barriers. Here we will review—starting with a deeper look into retroviral biology—how Murine Leukemia Virus (MLV), a simple gammaretrovirus, can be converted into an efficient vehicle of genetic therapeutics. Furthermore, we will describe how more rational vector backbones can be designed and how these so-called self-inactivating vectors can be pseudotyped and produced. Finally, we will provide an overview on existing clinical trials and how biosafety can be improved. |
format | Online Article Text |
id | pubmed-3185771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Molecular Diversity Preservation International (MDPI) |
record_format | MEDLINE/PubMed |
spelling | pubmed-31857712011-10-12 Gammaretroviral Vectors: Biology, Technology and Application Maetzig, Tobias Galla, Melanie Baum, Christopher Schambach, Axel Viruses Review Retroviruses are evolutionary optimized gene carriers that have naturally adapted to their hosts to efficiently deliver their nucleic acids into the target cell chromatin, thereby overcoming natural cellular barriers. Here we will review—starting with a deeper look into retroviral biology—how Murine Leukemia Virus (MLV), a simple gammaretrovirus, can be converted into an efficient vehicle of genetic therapeutics. Furthermore, we will describe how more rational vector backbones can be designed and how these so-called self-inactivating vectors can be pseudotyped and produced. Finally, we will provide an overview on existing clinical trials and how biosafety can be improved. Molecular Diversity Preservation International (MDPI) 2011-06-03 /pmc/articles/PMC3185771/ /pubmed/21994751 http://dx.doi.org/10.3390/v3060677 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Maetzig, Tobias Galla, Melanie Baum, Christopher Schambach, Axel Gammaretroviral Vectors: Biology, Technology and Application |
title | Gammaretroviral Vectors: Biology, Technology and Application |
title_full | Gammaretroviral Vectors: Biology, Technology and Application |
title_fullStr | Gammaretroviral Vectors: Biology, Technology and Application |
title_full_unstemmed | Gammaretroviral Vectors: Biology, Technology and Application |
title_short | Gammaretroviral Vectors: Biology, Technology and Application |
title_sort | gammaretroviral vectors: biology, technology and application |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185771/ https://www.ncbi.nlm.nih.gov/pubmed/21994751 http://dx.doi.org/10.3390/v3060677 |
work_keys_str_mv | AT maetzigtobias gammaretroviralvectorsbiologytechnologyandapplication AT gallamelanie gammaretroviralvectorsbiologytechnologyandapplication AT baumchristopher gammaretroviralvectorsbiologytechnologyandapplication AT schambachaxel gammaretroviralvectorsbiologytechnologyandapplication |